Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 61Active not recruiting 37Not yet recruiting 12Completed 9Terminated 4Withdrawn 2Suspended 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 1

Interventions

Specimen Handling 28Magnetic Resonance Spectroscopy 19Biopsy 18Cyclophosphamide 7venetoclax 5Vincristine 5Bevacizumab 5Surgical Procedures, Operative 4Radiotherapy, Intensity-Modulated 4Nivolumab 4Etoposide 4Azacitidine 4pembrolizumab 3fludarabine phosphate 3decitabine and cedazuridine drug combination 3X-Rays 3Taxes 3Radiosurgery 3Radiation 3Prednisone 3Injections 3Doxorubicin 3Cetuximab 3zanubrutinib 2trastuzumab deruxtecan 2prednylidene 2olaparib 2iadademstat 2fludarabine 2durvalumab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Suspended × 130-nm albumin-bound paclitaxel × 90 days × Clear all
NCT05685602 2026-05-18

CA-4948 Added to Standard Chemotherapy to Treat Metastatic or Unresectable Pancreatic Cancer

National Cancer Institute (NCI)

Phase 1 Suspended
43 enrolled
Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡